# A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome

> **NCT07552987** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Kedrion S.p.A.** · enrollment: 38 (estimated)

## Conditions studied

- Stiff Person Syndrome

## Interventions

- **BIOLOGICAL:** Kedrion IVIg 10%
- **BIOLOGICAL:** Human Albumin 5%

## Key facts

- **NCT ID:** NCT07552987
- **Lead sponsor:** Kedrion S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-01
- **Final completion:** 2028-07
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07552987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07552987, "A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07552987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*